Time to reconsider the role of ribavirin in Lassa fever.
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation o...
Guardado en:
Autores principales: | Alex Paddy Salam, Vincent Cheng, Tansy Edwards, Piero Olliaro, Jonathan Sterne, Peter Horby |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4763774884534bc790cd73d9a203fb9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.
por: Laura Merson, et al.
Publicado: (2021) -
Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone.
por: Mikaela R Koch, et al.
Publicado: (2021) -
Successful Outpatient Management of Children at a Secondary Care Hospital in Pakistan in a Dengue Fever Epidemic and Their Clinical Outcomes
por: Ammara Farooq, et al.
Publicado: (2021) -
Prevalence of Helicobacter pylori among Patients with Gastrointestinal Tract (GIT) Symptoms: A Retrospective Study at Selected Africa Air Rescue (AAR) Clinics in Kampala, Uganda, from 2015 to 2019
por: Edity Namyalo, et al.
Publicado: (2021) -
Water, Sanitation, and Hygiene Risk Factors on the Prevalence of Diarrhea among Under-Five Children in the Rural Community of Dangila District, Northwest Ethiopia
por: Bizuayehu Hailu, et al.
Publicado: (2021)